The shared allelic architecture of adiponectin levels and coronary artery disease

Atherosclerosis

Volumn 229, Issue 1, 2013, Pages 145-148

  Dastani, Zari ^a   Johnson, Toby ^b,c,d   Kronenberg, Florian ^e   Nelson, Christopher P ^f,g   Assimes, Themistocles L ^h   März, Winfried ⁱ   Brent Richards, J ^a,j  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^f UNIVERSITY OF LEICESTER   (United Kingdom)

^g GLENFIELD HOSPITAL   (United Kingdom)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ SYNLAB ACADEMY   (Germany)

^j KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Adiponectin; Association; Atherosclerosis; Coronary artery disease; Gene; SNP

Indexed keywords

ADIPONECTIN;

ALLELE; ARTICLE; CHROMOSOME 8; CORONARY ARTERY DISEASE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOME; GENOTYPE; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 84879415419     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.03.034     Document Type: Article

References (31)

1. WHO WHF World Stroke Organization, global atlas on cardiovascular disease prevention and control 2011, 164.
2. Nielsen S., Jensen M.D. Obesity and cardiovascular disease: is body structure a factor?. Curr Opin Lipidol 1997, 8:200-204.
3. Spiegelman B.M., Choy L., Hotamisligil G.S., Graves R.A., Tontonoz P. Regulation of adipocyte gene expression in differentiation and syndromes of obesity/diabetes. JBiol Chem 1993, 268:6823-6826.
4. Hivert M.F., Sullivan L.M., Fox C.S., et al. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. JClin Endocrinol Metab 2008, 93:3165-3172.
5. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA: J Am Med Assoc 2004, 291:1730-1737.
6. Kumada M., Kihara S., Sumitsuji S., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003, 23:85-89.
7. Dzielinska Z., Januszewicz A., Wiecek A., et al. Decreased plasma concentration of a novel anti-inflammatory protein-adiponectin-in hypertensive men with coronary artery disease. Thromb Res 2003, 110:365-369.
8. Lawlor D.A., Davey Smith G., Ebrahim S., Thompson C., Sattar N. Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. JClin Endocrinol Metab 2005, 90:5677-5683.
9. Zoccali C., Mallamaci F., Tripepi G., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. JAm Soc Nephrol 2002, 13:134-141.
10. Nakamura Y., Shimada K., Fukuda D., et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 2004, 90:528-533.
11. Qi L., Li T., Rimm E., et al. The+276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 2005, 54:1607-1610.
12. Lacquemant C., Froguel P., Lobbens S., Izzo P., Dina C., Ruiz J. The adiponectin gene SNP+45 is associated with coronary artery disease in Type 2 (non-insulin-dependent) diabetes mellitus. Diabet Med 2004, 21:776-781.
13. Filippi E., Sentinelli F., Romeo S., et al. The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age
14. Hara K., Boutin P., Mori Y., et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002, 51:536-540.
15. Ohashi K., Ouchi N., Kihara S., et al. Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. JAm Coll Cardiol 2004, 43:1195-1200.
16. Zhou L., Xi B., Wei Y., et al. Association between adiponectin gene polymorphisms and coronary artery disease across different populations. Thromb Res 2012, 130:52-57.
17. Heid I.M., Henneman P., Hicks A., et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2010, 208:412-420.
18. Richards J.B., Waterworth D., O'Rahilly S., et al. Agenome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet 2009, 5:e1000768.
19. Wu Y., Li Y., Lange E.M., et al. Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ. Hum Mol Genet 2010, 19:4955-4964.
20. Dastani Z., Hivert M.F., Timpson N., et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 2012, 8:e1002607.
21. Preuss M., Konig I.R., Thompson J.R., et al. Design of the Coronary ARtery DIsease Genome-Wide Replication and Meta-Analysis (CARDIoGRAM) Study: a genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet 2010, 3:475-483.
22. Nyholt D.R. Asimple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004, 74:765-769.
23. Kiss-Toth E., Bagstaff S.M., Sung H.Y., et al. Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. JBiol Chem 2004, 279:42703-42708.
24. Sung H.Y., Guan H., Czibula A., et al. Human tribbles-1 controls proliferation and chemotaxis of smooth muscle cells via MAPK signaling pathways. JBiol Chem 2007, 282:18379-18387.
25. Waterworth D.M., Ricketts S.L., Song K., et al. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol 2010, 30:2264-2276.
26. Teslovich T.M., Musunuru K., Smith A.V., et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466:707-713.
27. Chasman D.I., Pare G., Mora S., et al. Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLoS Genet 2009, 5:e1000730.
28. Kraja A.T., Vaidya D., Pankow J.S., et al. Abivariate genome-wide approach to metabolic syndrome: STAMPEED consortium. Diabetes 2011, 60:1329-1339.
29. Large-scale gene-centric analysis identifies novel variants for coronary artery disease. PLoS Genet 2011, 7:e1002260.
30. Burkhardt R., Toh S.A., Lagor W.R., et al. Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice. JClin Invest 2010, 120:4410-4414.
31. Lin YS-k L.I., Liang-yu X.I.A., Hui Y.A.N.G., Xun J.I.N., Shuang L.I. Relationship between TRIB1 gene s17321515 polymorphisms and type 2 diabetes mellitus in Han nationality from northern China, Clinical Chemistry. Abstracts of the scientific posters, 2011 AACC Annual Meeting 2011, 57.